Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
3 clinical trials · Condition
◉ Watch Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer (NCT00408694) | National Cancer Institute (NCI) | 2006-12-13 |
| Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma (NCT00336063) | National Cancer Institute (NCI) | 2006-03-03 |
| Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer (NCT00274937) | Children's Oncology Group | 2006-02-20 |
Track Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.